Published in Gut on April 01, 2005
Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol (2003) 6.05
Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest (2004) 5.14
Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology (1992) 4.19
Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol (2002) 3.98
Current concepts of celiac disease pathogenesis. Gastroenterology (2000) 3.23
Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat (2002) 2.92
AGA technical review on Celiac Sprue. American Gastroenterological Association. Gastroenterology (2001) 2.53
Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med (1987) 2.02
Bactericidal properties of murine intestinal phospholipase A2. J Clin Invest (1995) 1.75
Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question. Trends Immunol (2001) 1.52
Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis. J Clin Invest (2003) 1.08
Core histones are glutaminyl substrates for tissue transglutaminase. J Biol Chem (1996) 0.93
Differential expression of multiple transglutaminases in human colon: impaired keratinocyte transglutaminase expression in ulcerative colitis. Gut (2005) 0.88
Transglutaminases in Crohn's disease. Gut (1995) 0.87
Substitution of factor XIII: a therapeutic approach to ulcerative colitis. Haemostasis (1991) 0.87
Lack of clinical efficacy of additional factor XIII treatment in patients with steroid refractory colitis. The Factor XIII Study Group. Z Gastroenterol (1999) 0.81
Significance of diminished factor XIII in Crohn's disease. Am J Gastroenterol (1998) 0.81
Transglutaminase in azoxymethane-induced colon cancer in the rat. Dig Dis Sci (1995) 0.78
Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV. Gastroenterology (1991) 2.42
Rapid mucosal CD4(+) T-cell depletion and enteropathy in simian immunodeficiency virus-infected rhesus macaques. Gastroenterology (1999) 2.20
Diagnostic value of confocal endomicroscopy in celiac disease. Endoscopy (2010) 2.15
[S3-Guidelines Conference "Colorectal Carcinoma" 2004]. Z Gastroenterol (2004) 2.03
Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann Intern Med (1989) 1.99
T cell differentiation antigens on lymphocytes in the human intestinal lamina propria. J Immunol (1992) 1.94
Comparison of computed tomography, endosonography, and intraoperative assessment in TN staging of gastric carcinoma. Gut (1993) 1.83
Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut (2004) 1.82
Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am J Gastroenterol (2001) 1.70
Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut (2008) 1.65
Recent results in understanding molecular pathways in the medical treatment of esophageal and gastric cancer. Onkologie (2004) 1.48
Evaluation of endosonography in sclerotherapy of esophageal varices. Endoscopy (1991) 1.39
The HML-1 antigen of intestinal lymphocytes is an activation antigen. J Immunol (1990) 1.36
Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease. Gut (2003) 1.24
gamma delta T cells in the human intestine express surface markers of activation and are preferentially located in the epithelium. Cell Immunol (1990) 1.23
S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII). Z Gastroenterol (2010) 1.20
[Clinical practice guideline on diagnosis and treatment of Crohn's disease]. Z Gastroenterol (2008) 1.19
Structural and functional changes of the duodenum in human norovirus infection. Gut (2008) 1.18
Mechanisms of epithelial translocation of the alpha(2)-gliadin-33mer in coeliac sprue. Gut (2008) 1.17
Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice. Gut (2004) 1.17
Identification of a T cell lymphoma category derived from intestinal-mucosa-associated T cells. Lancet (1988) 1.15
Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice. Gut (2008) 1.13
Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis. Gut (2000) 1.11
CD4 positive Leu-8 negative helper-inducer T cells predominate in the human intestinal lamina propria. J Immunol (1988) 1.11
[Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011]. Z Gastroenterol (2011) 1.11
Evaluation of endosonography in TN staging of oesophageal cancer. Gut (1991) 1.10
Mucosal atrophy is associated with loss of activated T cells in the duodenal mucosa of human immunodeficiency virus (HIV)-infected patients. Digestion (1990) 1.10
Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques. Gut (2002) 1.09
Toll-like receptor expression and response to specific stimulation in adipocytes and preadipocytes: on the role of fat in inflammation. Ann N Y Acad Sci (2006) 1.09
[Methodological basis for the development of consensus recommendations]. Z Gastroenterol (2004) 1.09
Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells. Br J Cancer (2001) 1.07
[Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas]. Dtsch Med Wochenschr (1995) 1.07
Enteric immunologic abnormalities in human immunodeficiency virus infection. Semin Liver Dis (1992) 1.06
Ion transport in the experimental short bowel syndrome of the rat. Gastroenterology (1992) 1.04
Isolation of Nocardia paucivorans from the cerebrospinal fluid of a patient with relapse of cerebral nocardiosis. J Clin Microbiol (2002) 1.03
Mucosal HIV infection. Pathobiology (1998) 1.02
Capsule endoscopy in refractory celiac disease. Endoscopy (2007) 1.01
Abnormalities in subset distribution, activation, and differentiation of T cells isolated from large intestine biopsies in HIV infection. The Berlin Diarrhoea/Wasting Syndrome Study Group. Clin Exp Immunol (1994) 1.00
Defining the role of T cell-derived leptin in the modulation of hepatic or intestinal inflammation in mice. Clin Exp Immunol (2005) 0.99
[The norovirus-epidemic in Berlin - clinic, epidemiology, and prevention]. Z Gastroenterol (2004) 0.98
[Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease]. Z Gastroenterol (2004) 0.97
The gut as an organ of immunology. Int J Colorectal Dis (2002) 0.97
HIV-1 p24 but not proviral load is increased in the intestinal mucosa compared with the peripheral blood in HIV-infected patients. AIDS (1998) 0.97
Protection of trinitrobenzene sulfonic acid-induced colitis by an interleukin 2-IgG2b fusion protein in mice. Gastroenterology (1999) 0.95
Groove pancreatitis: an important differential diagnosis to malignant stenosis of the duodenum. Dig Dis Sci (2001) 0.94
Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y(2)-receptors. Br J Cancer (2002) 0.94
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003. Int J Colorectal Dis (2001) 0.94
Increased immunoglobulin G production by short term cultured duodenal biopsy samples from HIV infected patients. Gut (1998) 0.94
Adipokine signaling in inflammatory bowel disease. Inflamm Bowel Dis (2009) 0.93
Immunological and trophical effects of Saccharomyces boulardii on the small intestine in healthy human volunteers. Digestion (1996) 0.93
Growth inhibition and apoptosis induced by P2Y2 receptors in human colorectal carcinoma cells: involvement of intracellular calcium and cyclic adenosine monophosphate. Int J Colorectal Dis (2001) 0.93
Abnormal predominance of IgG in HIV-specific antibodies produced by short-term cultured duodenal biopsy specimens from HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.93
Treatment of refractory Whipple disease with interferon-gamma. Ann Intern Med (1998) 0.93
The immunologic aspects of human immunodeficiency virus infection in the gastrointestinal tract. Semin Gastrointest Dis (1996) 0.92
Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease. Gut (1984) 0.92
Extinction of IL-12 signaling promotes Fas-mediated apoptosis of antigen-specific T cells. J Immunol (1999) 0.92
Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth. Oncogene (2006) 0.91
Predominance of helper-inducer T cells in mesenteric lymph nodes and intestinal lamina propria of normal nonhuman primates. Cell Immunol (1987) 0.91
The double duct sign in patients with malignant and benign pancreatic lesions. Gastrointest Endosc (2000) 0.90
Collagen metabolism in granulating wounds of rat skin. Arch Dermatol Res (1978) 0.90
Increased state of activation of CD4 positive T cells and elevated interferon gamma production in pouchitis. Gut (1998) 0.90
Autochthonous hepatitis E virus infection in Germany with sequence similarities to other European isolates. Infection (2006) 0.90
Human immunodeficiency virus-induced enteropathy. Immunol Res (1991) 0.90
Cytotoxic and immunoregulatory function of intestinal lymphocytes in Chlamydia trachomatis proctitis of nonhuman primates. Infect Immun (1987) 0.89
Mucosal abnormalities in microsporidiosis. AIDS (1997) 0.89
Effects of zidovudine treatment on the small intestinal mucosa in patients infected with the human immunodeficiency virus. Gastroenterology (1992) 0.89
Confocal neurolasermicroscopy in human brain - perspectives for neurosurgery on a cellular level (including additional comments to this article). Cent Eur Neurosurg (2009) 0.89
Increased matrix metalloproteinase 2 concentration and transcript expression in advanced colorectal carcinomas. Int J Colorectal Dis (2001) 0.89
Intestinal T-cell lymphoma: a reassessment of cytomorphological and phenotypic features in relation to patterns of small bowel remodelling. Virchows Arch (1996) 0.89
ZM447439, a novel promising aurora kinase inhibitor, provokes antiproliferative and proapoptotic effects alone and in combination with bio- and chemotherapeutic agents in gastroenteropancreatic neuroendocrine tumor cell lines. Neuroendocrinology (2009) 0.88
Serum carotene deficiency in HIV-infected patients. Berlin Diarrhoea/Wasting Syndrome Study Group. AIDS (1994) 0.88
Decreased expression of CD44 splicing variants in advanced colorectal carcinomas. Eur J Cancer (1998) 0.88
Effect of psychotherapy on the course of Crohn's disease. Results of the German prospective multicenter psychotherapy treatment study on Crohn's disease. German Study Group on Psychosocial Intervention in Crohn's Disease. Scand J Gastroenterol (1998) 0.87
Development of ulcerative colitis under the immunosuppressive effect of cyclosporine. Clin Investig (1992) 0.86
CD44v7 ligation downregulates the inflammatory immune response in Crohn's disease patients by apoptosis induction in mononuclear cells from the lamina propria. Cell Death Differ (2007) 0.85
Tight junction regulation during impaired ion transport in blind loops of rat jejunum. Res Exp Med (Berl) (1990) 0.85
The effect of an anthraquinone laxative on colonic nerve tissue: a controlled trial in constipated women. Z Gastroenterol (1990) 0.85
Mesenteric fat - control site for bacterial translocation in colitis? Mucosal Immunol (2012) 0.85
[Diagnosis and therapy of ulcerative colitis--results of an evidence-based consensus conference of the German Society of Digestive and Metabolic Diseases]. Z Gastroenterol (2001) 0.85
Non-opportunistic causes of diarrhoea in HIV infection. Baillieres Clin Gastroenterol (1990) 0.85
A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839). Br J Cancer (2003) 0.85
Decreased levels of interleukin-12p40 in the serum of patients with Whipple's disease. Int J Colorectal Dis (2005) 0.84
Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells. Int J Colorectal Dis (2002) 0.84
In vivo diagnosis of intestinal spirochaetosis by confocal endomicroscopy. Gut (2008) 0.84
Screening for oesophageal neoplasia in patients with head and neck cancer. Br J Cancer (2002) 0.84
[Appendectomy reduces the risk of development of ulcerative colitis]. Chirurg (2002) 0.84
Immunopathology of human immunodeficiency virus infection in the gastrointestinal tract. Springer Semin Immunopathol (1997) 0.83
Preoperative staging of gastrointestinal tumors by endosonography. Surg Endosc (1990) 0.83
[Diagnostics and treatment of Crohn's disease -- results of an evidence-based consensus conference of the German Society for Digestive and Metabolic Diseases]. Z Gastroenterol (2003) 0.83
[S3-guideline conference "Colorectal Cancer" 2004]. Dtsch Med Wochenschr (2005) 0.83
Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy. Gastroenterology (2000) 0.83
The interleukin-2-deficient mouse model. Pathobiology (2003) 0.82